Position in LLY
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$8,408,005
+$3,823,872 QoQ
Shares Held
7,010
+40.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.40%
of 13F equity value
Holder Rank
#1,357
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Pure Financial Advisors, LLC holds $38,114,911 across 13 Drug Manufacturers - General names. LLY ranks #1 (22.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
7,010 | $8,408,005 | |
| 2 | MRK |
Merck & Co., Inc.
|
59,640 | $7,663,740 | |
| 3 | JNJ |
Johnson & Johnson
|
29,199 | $7,415,670 | |
| 4 | ABBV |
AbbVie Inc.
|
23,887 | $6,010,924 | |
| 5 | AMGN |
Amgen Inc
|
7,972 | $2,886,820 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
22,483 | $1,295,470 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
7,775 | $982,293 | |
| 8 | NVO |
Novo Nordisk A S
|
16,779 | $804,385 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,408,005 | 7,010 | Shares | Sole | 2026-08-17 | |
| 2026-03-31 | $4,584,133 | 4,984 | Shares | Sole | 2026-04-10 | |
| 2025-12-31 | $4,802,745 | 4,469 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $3,296,160 | 4,320 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $3,518,798 | 4,514 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $3,198,749 | 3,873 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $2,630,204 | 3,407 | Shares | Sole | 2025-01-16 | |
| 2024-09-30 | $2,081,073 | 2,349 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $4,784,027 | 5,284 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $4,200,206 | 5,399 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $2,548,526 | 4,372 | Shares | Sole | 2024-01-08 | |
| 2023-09-30 | $2,418,159 | 4,502 | Shares | Sole | 2023-10-10 | |
| 2023-06-30 | $1,767,116 | 3,768 | Shares | Sole | 2023-07-10 | |
| 2023-03-31 | $1,297,784 | 3,779 | Shares | Sole | 2023-04-11 | |
| 2022-12-31 | $1,463,725 | 4,001 | Shares | Sole | 2023-01-09 | |
| 2022-09-30 | $1,279,495 | 3,957 | Shares | Sole | 2022-10-06 | |
| 2022-06-30 | $1,223,319 | 3,773 | Shares | Sole | 2022-07-08 | |
| 2022-03-31 | $881,160 | 3,077 | Shares | Sole | 2022-04-12 | |
| 2021-12-31 | $781,702 | 2,830 | Shares | Sole | 2022-01-12 | |
| 2021-09-30 | $640,932 | 2,774 | Shares | Sole | 2021-10-07 | |
| 2021-06-30 | $576,554 | 2,512 | Shares | Sole | 2021-07-09 | |
| 2021-03-31 | $469,291 | 2,512 | Shares | Sole | 2021-04-09 | |
| 2020-12-31 | $424,126 | 2,512 | Shares | Sole | 2021-01-12 | |
| 2020-09-30 | $371,826 | 2,512 | Shares | Sole | 2020-10-07 | |
| 2020-06-30 | $412,420 | 2,512 | Shares | Sole | 2020-07-08 | |
| 2020-03-31 | $347,354 | 2,504 | Shares | Sole | 2020-04-07 | |
| No filing history on record for this holder in this stock. | ||||||